Objective
The high failure rate of drug candidates in late-stage development poses a significant challenge to the pharmaceutical industry. This is primarily attributed to unforeseen toxicity, off-target effects, and lack of efficacy.
Current imaging techniques, such as MRI and PET, lack the resolution to provide a comprehensive, single cell view of therapeutic distribution within an organism. This limitation is particularly crucial for advanced therapies like mRNA-based drugs, gene therapies, and nanocarriers, which necessitate precise cellular targeting. The inability to track these therapies in sufficient detail results in late-stage failures, increased costs, and greater reliance on animal testing.
Deep Piction’s mission is to transform targeted therapeutic development by providing unparalleled cell-level insights into drug distribution, targeting, and efficacy through our proprietary AI-driven whole-body cellular imaging technology.
As the only company offering this level of spatial and molecular detail, we empower biopharmaceutical companies to optimise therapeutic molecules with unmatched precision - reducing off-target toxicity and enhancing treatment efficacy.
Deep Piction is unique: zero-slicing, entire-organism coverage, single-cell detail, plus optional mRNA/protein labeling. Our robust patent portfolio - transferred from our academic roots - protects the unique chemistry, optics, and computational methods that power our breakthrough.
By bridging the gap between preclinical research and clinical success, we drive the development of safer, more effective drugs and expand the potential for next-generation therapies through precise cell- level targeting.
With the EIC funding, we will finalise the standardisation of mRNA labeling in entire adult mouse bodies, scale our commercial efforts, and remain the only solution offering such transformative 3D subcellular analysis.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- medical and health sciences medical biotechnology genetic engineering gene therapy
- natural sciences computer and information sciences computational science
- medical and health sciences health sciences personalized medicine
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.3.1 - The European Innovation Council (EIC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-EIC-ACC - HORIZON EIC Accelerator
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-EIC-2025-ACCELERATOR-02
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
85764 Neuherberg
Germany
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.